Royalty drops hostile bid for Ireland's Elan
By Padraic Halpin DUBLIN (Reuters) - U.S.-based Royalty Pharma has dropped a hostile bid worth up to $8 billion for Elan , leaving t...
Read More »By Padraic Halpin DUBLIN (Reuters) - U.S.-based Royalty Pharma has dropped a hostile bid worth up to $8 billion for Elan , leaving t...
Read More »
By Alwyn Scott and Tim Hepher PARIS (Reuters) - Boeing launched a larger version of its flagship Dreamliner aircraft at the Paris A...
Read More »
(Reuters) - Hong Kong's de facto central bank said on Tuesday that its investigation into possible benchmark rate manipulation has b...
Read More »
By Matt Scuffham and Steve Slater LONDON (Reuters) - British bank Lloyds has denied being subject to political pressure to sell hun...
Read More »
By Ayai Tomisawa TOKYO (Reuters) - Japan's Nikkei will rise 51 percent in 2013 on expectations of higher company earnings, driven by...
Read More »
BERLIN (Reuters) - European car sales last month plunged to the lowest level in two decades for May, further eroding manufacturers' ...
Read More »
FRANKFURT (Reuters) - German lender Commerzbank will shed more than 5,000 jobs, 10 percent of its workforce, under a preliminary dea...
Read More »
By Kirstin Ridley LONDON (Reuters) - Britain's fraud prosecutor on Tuesday charged former UBS and Citigroup trader Tom Hayes with ...
Read More »
PARIS (Reuters) - Boeing launched the 787-10 version of its flagship Dreamliner aircraft at the Paris Airshow on Tuesday with 102 f...
Read More »PARIS (Reuters) - Pratt & Whitney said on Tuesday that it expects to log 1,000 orders for its geared turbo fan aircraft engine at t...
Read More »